Aristo Bio-Tech and Lifescience (NSE:ARISTO) Total Receivables: ₹562 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹115.00
View Full Analysis

What is Aristo Bio-Tech and Lifescience Total Receivables?

Aristo Bio-Tech and Lifescience NSE:ARISTO 59 Total Receivables is ₹562 Mil as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

Aristo Bio-Tech and Lifescience's Total Receivables for the quarter that ended in Mar. 2025 was ₹562 Mil.

Aristo Bio-Tech and Lifescience Total Receivables Related Terms

Aristo Bio-Tech and Lifescience Total Receivables Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience Total Receivables Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Receivables
Get a 7-Day Free Trial 327.66 332.00 445.73 574.73 561.84

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Receivables Get a 7-Day Free Trial Premium Member Only 445.73 789.63 574.73 1,535.91 561.84
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹562 Mil mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a Total Receivables of ₹562 Mil as of Mar. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's Total Receivables too high?
Aristo Bio-Tech and Lifescience's current Total Receivables is ₹562 Mil. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's Total Receivables compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's Total Receivables of ₹562 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for an Agriculture company?
A good Total Receivables depends on the Agriculture industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current Total Receivables is ₹562 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current Total Receivables of ₹562 Mil. The current Total Receivables is ₹562 Mil. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current Total Receivables is ₹562 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹115.00
Price